NCT06757062 Efficacy of Red Kinesiology Tape on Carpal Tunnel-Like Symptoms and Performance in Esports Gamers
| NCT ID | NCT06757062 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nevada, Las Vegas |
| Condition | Carpal Tunnel Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2025-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-01-01 with a primary completion date of 2025-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if dorsally applied kinesiology tape is an effective conservative treatment for symptoms of carpal tunnel syndrome and assess the potential performance effect of the tape color in first-person shooter esports games in esports gamers who exhibit symptoms that resemble carpal tunnel syndrome. The main questions it aims to answer are: Is dorsally applied kinesiology tape able to manage carpal tunnel syndrome-like symptoms in esports gamers? Does red kinesiology tape hinder or improve performance in first-person shooter esports games in esports gamers? Researchers will compare red kinesiology tape to skin tone kinesiology tape. Both will be applied on the dorsal aspect of the hand and wrist of the dominant upper extremity. Participants will visit the site 2 times to get kinesiology tape applied and complete a pre and post-test for pain and performance. Depending on randomization a participant will receive a random sequence of the study arm (ex: red then skin tone or skin tone then red tape)
Eligibility Criteria
Inclusion Criteria: * over 18 years old * can see color vision * reports having numbness, tingling, weakness, or pain in the hands, wrist, or fingers * has a positive Phalen's test result * passes Ishihara Color Vision Test with a score of at least 12 * provides written consent * reports to play video games over 5 hours a week on average Exclusion Criteria: * cognitively impaired * pregnant * has history of skin conditions * has history of hand conditions other than carpal tunnel syndrome * has history of surgery to the wrist, hand, or fingers * is currently receiving other forms of physiotherapy * has open wounds on the kinesiology tape application site
Contact & Investigator
Donnamarie Krause, Ph.D
PRINCIPAL INVESTIGATOR
University of Nevada, Las Vegas
Frequently Asked Questions
Who can join the NCT06757062 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Carpal Tunnel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06757062 currently recruiting?
Yes, NCT06757062 is actively recruiting participants. Contact the research team at taings3@unlv.nevada.edu for enrollment information.
Where is the NCT06757062 trial being conducted?
This trial is being conducted at Las Vegas, United States.
Who is sponsoring the NCT06757062 clinical trial?
NCT06757062 is sponsored by University of Nevada, Las Vegas. The principal investigator is Donnamarie Krause, Ph.D at University of Nevada, Las Vegas. The trial plans to enroll 30 participants.